Behavioural Health Software Market (By Component: Services, Software; By Delivery: Subscription, Ownership; By Functionality: Clinical, EHR, CDS, Telehealth, RCM, BI, Administrative, Financial; By End User: Hospitals, Clinics) - Global Industry Analysis, Size, Share, Growth, Trends, Revenue, Regional Outlook and Forecast 2021-2030

Table of Contents

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope 

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis 

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. Market Dynamics Analysis and Trends

5.1. Market Dynamics

5.1.1. Market Drivers

5.1.2. Market Restraints

5.1.3. Market Opportunities

5.2. Porter’s Five Forces Analysis

5.2.1. Bargaining power of suppliers

5.2.2. Bargaining power of buyers

5.2.3. Threat of substitute

5.2.4. Threat of new entrants

5.2.5. Degree of competition

Chapter 6. Competitive Landscape

6.1.1. Company Market Share/Positioning Analysis

6.1.2. Key Strategies Adopted by Players

6.1.3. Vendor Landscape

6.1.3.1. List of Suppliers

6.1.3.2. List of Buyers

Chapter 7. Global Behavioural Health Software Market, By Component

7.1. Behavioural Health Software Market, by Component Type, 2021-2030

7.1.1. Support Services

7.1.1.1. Market Revenue and Forecast (2017-2030)

7.1.2. Software (Integrated Software, Standalone Software)

7.1.2.1. Market Revenue and Forecast (2017-2030)

Chapter 8. Global Behavioural Health Software Market, By Delivery Model

8.1. Behavioural Health Software Market, by Delivery Model, 2021-2030

8.1.1. Subscription Models

8.1.1.1. Market Revenue and Forecast (2017-2030)

8.1.2. Ownership Models

8.1.2.1. Market Revenue and Forecast (2017-2030)

Chapter 9. Global Behavioural Health Software Market, By Functionality Type 

9.1. Behavioural Health Software Market, by Functionality Type, 2021-2030

9.1.1. Clinical Functionality (EHR, CDS, E-Prescribing, Telehealth)

9.1.1.1. Market Revenue and Forecast (2017-2030)

9.1.2. Administrative Functionality

9.1.2.1. Market Revenue and Forecast (2017-2030)

9.1.3. Financial Functionality

9.1.3.1. Market Revenue and Forecast (2017-2030)

Chapter 10. Global Behavioural Health Software Market, By End User Type 

10.1. Behavioural Health Software Market, by End User Type, 2021-2030

10.1.1. Community Clinics

10.1.1.1. Market Revenue and Forecast (2017-2030)

10.1.2. Hospitals

10.1.2.1. Market Revenue and Forecast (2017-2030)

10.1.3. Private Practices

10.1.3.1. Market Revenue and Forecast (2017-2030)

Chapter 11. Global Behavioural Health Software Market, Regional Estimates and Trend Forecast

11.1. North America

11.1.1. Market Revenue and Forecast, by Component (2017-2030)

11.1.2. Market Revenue and Forecast, by Delivery Model (2017-2030)

11.1.3. Market Revenue and Forecast, by Functionality Type (2017-2030)

11.1.4. Market Revenue and Forecast, by End User Type (2017-2030)

11.1.5. U.S.

11.1.5.1. Market Revenue and Forecast, by Component (2017-2030)

11.1.5.2. Market Revenue and Forecast, by Delivery Model (2017-2030)

11.1.5.3. Market Revenue and Forecast, by Functionality Type (2017-2030)

11.1.5.4. Market Revenue and Forecast, by End User Type (2017-2030)

11.1.6. Rest of North America

11.1.6.1. Market Revenue and Forecast, by Component (2017-2030)

11.1.6.2. Market Revenue and Forecast, by Delivery Model (2017-2030)

11.1.6.3. Market Revenue and Forecast, by Functionality Type (2017-2030)

11.1.6.4. Market Revenue and Forecast, by End User Type (2017-2030)

11.2. Europe

11.2.1. Market Revenue and Forecast, by Component (2017-2030)

11.2.2. Market Revenue and Forecast, by Delivery Model (2017-2030)

11.2.3. Market Revenue and Forecast, by Functionality Type (2017-2030)

11.2.4. Market Revenue and Forecast, by End User Type (2017-2030)

11.2.5. UK

11.2.5.1. Market Revenue and Forecast, by Component (2017-2030)

11.2.5.2. Market Revenue and Forecast, by Delivery Model (2017-2030)

11.2.5.3. Market Revenue and Forecast, by Functionality Type (2017-2030)

11.2.5.4. Market Revenue and Forecast, by End User Type (2017-2030)

11.2.6. Germany

11.2.6.1. Market Revenue and Forecast, by Component (2017-2030)

11.2.6.2. Market Revenue and Forecast, by Delivery Model (2017-2030)

11.2.6.3. Market Revenue and Forecast, by Functionality Type (2017-2030)

11.2.6.4. Market Revenue and Forecast, by End User Type (2017-2030)

11.2.7. France

11.2.7.1. Market Revenue and Forecast, by Component (2017-2030)

11.2.7.2. Market Revenue and Forecast, by Delivery Model (2017-2030)

11.2.7.3. Market Revenue and Forecast, by Functionality Type (2017-2030)

11.2.7.4. Market Revenue and Forecast, by End User Type (2017-2030)

11.2.8. Rest of Europe

11.2.8.1. Market Revenue and Forecast, by Component (2017-2030)

11.2.8.2. Market Revenue and Forecast, by Delivery Model (2017-2030)

11.2.8.3. Market Revenue and Forecast, by Functionality Type (2017-2030)

11.2.8.4. Market Revenue and Forecast, by End User Type (2017-2030)

11.3. APAC

11.3.1. Market Revenue and Forecast, by Component (2017-2030)

11.3.2. Market Revenue and Forecast, by Delivery Model (2017-2030)

11.3.3. Market Revenue and Forecast, by Functionality Type (2017-2030)

11.3.4. Market Revenue and Forecast, by End User Type (2017-2030)

11.3.5. India

11.3.5.1. Market Revenue and Forecast, by Component (2017-2030)

11.3.5.2. Market Revenue and Forecast, by Delivery Model (2017-2030)

11.3.5.3. Market Revenue and Forecast, by Functionality Type (2017-2030)

11.3.5.4. Market Revenue and Forecast, by End User Type (2017-2030)

11.3.6. China

11.3.6.1. Market Revenue and Forecast, by Component (2017-2030)

11.3.6.2. Market Revenue and Forecast, by Delivery Model (2017-2030)

11.3.6.3. Market Revenue and Forecast, by Functionality Type (2017-2030)

11.3.6.4. Market Revenue and Forecast, by End User Type (2017-2030)

11.3.7. Japan

11.3.7.1. Market Revenue and Forecast, by Component (2017-2030)

11.3.7.2. Market Revenue and Forecast, by Delivery Model (2017-2030)

11.3.7.3. Market Revenue and Forecast, by Functionality Type (2017-2030)

11.3.7.4. Market Revenue and Forecast, by End User Type (2017-2030)

11.3.8. Rest of APAC

11.3.8.1. Market Revenue and Forecast, by Component (2017-2030)

11.3.8.2. Market Revenue and Forecast, by Delivery Model (2017-2030)

11.3.8.3. Market Revenue and Forecast, by Functionality Type (2017-2030)

11.3.8.4. Market Revenue and Forecast, by End User Type (2017-2030)

11.4. MEA

11.4.1. Market Revenue and Forecast, by Component (2017-2030)

11.4.2. Market Revenue and Forecast, by Delivery Model (2017-2030)

11.4.3. Market Revenue and Forecast, by Functionality Type (2017-2030)

11.4.4. Market Revenue and Forecast, by End User Type (2017-2030)

11.4.5. GCC

11.4.5.1. Market Revenue and Forecast, by Component (2017-2030)

11.4.5.2. Market Revenue and Forecast, by Delivery Model (2017-2030)

11.4.5.3. Market Revenue and Forecast, by Functionality Type (2017-2030)

11.4.5.4. Market Revenue and Forecast, by End User Type (2017-2030)

11.4.6. North Africa

11.4.6.1. Market Revenue and Forecast, by Component (2017-2030)

11.4.6.2. Market Revenue and Forecast, by Delivery Model (2017-2030)

11.4.6.3. Market Revenue and Forecast, by Functionality Type (2017-2030)

11.4.6.4. Market Revenue and Forecast, by End User Type (2017-2030)

11.4.7. South Africa

11.4.7.1. Market Revenue and Forecast, by Component (2017-2030)

11.4.7.2. Market Revenue and Forecast, by Delivery Model (2017-2030)

11.4.7.3. Market Revenue and Forecast, by Functionality Type (2017-2030)

11.4.7.4. Market Revenue and Forecast, by End User Type (2017-2030)

11.4.8. Rest of MEA

11.4.8.1. Market Revenue and Forecast, by Component (2017-2030)

11.4.8.2. Market Revenue and Forecast, by Delivery Model (2017-2030)

11.4.8.3. Market Revenue and Forecast, by Functionality Type (2017-2030)

11.4.8.4. Market Revenue and Forecast, by End User Type (2017-2030)

11.5. Latin America

11.5.1. Market Revenue and Forecast, by Component (2017-2030)

11.5.2. Market Revenue and Forecast, by Delivery Model (2017-2030)

11.5.3. Market Revenue and Forecast, by Functionality Type (2017-2030)

11.5.4. Market Revenue and Forecast, by End User Type (2017-2030)

11.5.5. Brazil

11.5.5.1. Market Revenue and Forecast, by Component (2017-2030)

11.5.5.2. Market Revenue and Forecast, by Delivery Model (2017-2030)

11.5.5.3. Market Revenue and Forecast, by Functionality Type (2017-2030)

11.5.5.4. Market Revenue and Forecast, by End User Type (2017-2030)

11.5.6. Rest of LATAM

11.5.6.1. Market Revenue and Forecast, by Component (2017-2030)

11.5.6.2. Market Revenue and Forecast, by Delivery Model (2017-2030)

11.5.6.3. Market Revenue and Forecast, by Functionality Type (2017-2030)

11.5.6.4. Market Revenue and Forecast, by End User Type (2017-2030)

Chapter 12. Company Profiles

12.1. AdvancedMD

12.1.1. Company Overview

12.1.2. Product Offerings

12.1.3. Financial Performance

12.1.4. Recent Initiatives

12.2. Nextgen

12.2.1. Company Overview

12.2.2. Product Offerings

12.2.3. Financial Performance

12.2.4. Recent Initiatives

12.3. Compulink

12.3.1. Company Overview

12.3.2. Product Offerings

12.3.3. Financial Performance

12.3.4. Recent Initiatives

12.4. Cerner

12.4.1. Company Overview

12.4.2. Product Offerings

12.4.3. Financial Performance

12.4.4. Recent Initiatives

12.5. Core Solutions

12.5.1. Company Overview

12.5.2. Product Offerings

12.5.3. Financial Performance

12.5.4. Recent Initiatives

12.6. Credible Behavioral Health

12.6.1. Company Overview

12.6.2. Product Offerings

12.6.3. Financial Performance

12.6.4. Recent Initiatives

12.7. InSync Healthcare Soulutions

12.7.1. Company Overview

12.7.2. Product Offerings

12.7.3. Financial Performance

12.7.4. Recent Initiatives

12.8. Isalus Healthcare

12.8.1. Company Overview

12.8.2. Product Offerings

12.8.3. Financial Performance

12.8.4. Recent Initiatives

12.9. ICA Notes

12.9.1. Company Overview

12.9.2. Product Offerings

12.9.3. Financial Performance

12.9.4. Recent Initiatives

12.10. Kareo

12.10.1. Company Overview

12.10.2. Product Offerings

12.10.3. Financial Performance

12.10.4. Recent Initiatives

12.11. NextStep Solutions

12.11.1. Company Overview

12.11.2. Product Offerings

12.11.3. Financial Performance

12.11.4. Recent Initiatives

Chapter 13. Research Methodology

13.1. Primary Research

13.2. Secondary Research

13.3. Assumptions

Chapter 14. Appendix

14.1. About Us

14.2. Glossary of Terms

Report Details

  • Report Code:38246
  • Category:Healthcare
  • No. of Pages:150+
  • Format:PDF/PPT/Excel
  • Published:August 2021
  • Historical Year:2021-2022
  • Base Year:2023
  • Estimated Year:2024-2033

Proceed To Buy

USD 4500
USD 3800
USD 1900
USD 1200

Customization Offered

  • check-imgCross-segment Market Size and Analysis for Mentioned Segments
  • check-imgAdditional Company Profiles (Upto 5 With No Cost)
  • check-img Additional Countries (Apart From Mentioned Countries)
  • check-img Country/Region-specific Report
  • check-img Go To Market Strategy
  • check-imgRegion Specific Market Dynamics
  • check-imgRegion Level Market Share
  • check-img Import Export Analysis
  • check-imgProduction Analysis
  • check-imgOthers